$0.5431
-0.00270-0.49%
At close: -
$0.5271
-0.02-2.95%
After Hours: 7:13 PM EDT
Comments
Loading...
Harvard Bioscience (HBIO) Forecast
NewsEarningsOptionsGuidanceAnalyst RatingsInsider TradesShort InterestStock ReportEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Harvard Bioscience Stock Price, Quotes and Forecasts | NASDAQ:HBIO | Benzinga
Explore Harvard Bioscience stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HBIO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Harvard Bioscience (HBIO) stock?
You can purchase shares of Harvard Bioscience (NASDAQ:HBIO) through any online brokerage.
Who are Harvard Bioscience (HBIO) competitors?
Other companies in Harvard Bioscience’s space includes: Codexis (NASDAQ:CDXS), Inotiv (NASDAQ:NOTV), Lifecore Biomedical (NASDAQ:LFCR), Atlantic International (NASDAQ:ATLN) and Bionano Genomics (NASDAQ:BNGO).
What is the forecast, or price target, for Harvard Bioscience (HBIO) stock?
Harvard Bioscience has a consensus price target of $3.00.
What is the current price for Harvard Bioscience (HBIO)?
The stock price for Harvard Bioscience (NASDAQ: HBIO) is $0.5271 last updated November 7, 2025 at 7:13 PM EST.
Does Harvard Bioscience (HBIO) pay a dividend?
There are no upcoming dividends for Harvard Bioscience.
When is Harvard Bioscience (NASDAQ:HBIO) reporting earnings?
Harvard Bioscience’s Q3 earnings are confirmed for Thursday, November 6, 2025.
Is Harvard Bioscience (HBIO) going to split?
There is no upcoming split for Harvard Bioscience.
What sector and industry does Harvard Bioscience (HBIO) operate in?
Harvard Bioscience is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
